spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare News Roundup: Biopharmaceutical

 HSMN NewsFeed - 11 Aug 2010
Alectos Therapeutics Announces Collaboration With Merck to Develop Drugs for Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 Aug 2010
Bionovo Adds Dr. James H. Pickar, Former Executive at Wyeth, to Medical Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Aug 2010
Dicerna Closes $25 Million Series B Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 10 Aug 2010
Advanced Life Sciences Achieves Special Protocol Assessment Agreement With FDA for Restanza in Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Aug 2010
Labopharm announces U.S. launch of OLEPTRO(TM) for treatment of major depressive disorder in adults
Biopharmaceuticals
 HSMN NewsFeed - 10 Aug 2010
Avid Radiopharmaceuticals Expands R&D Capabilities with Appointment of Dr. Mark A. Mintun as Chief Medical Officer
Biopharmaceuticals Radiology Neurology Personnel
 HSMN NewsFeed - 10 Aug 2010
DiaMedica Announces Dr. Michael Giuffre to Join Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Aug 2010
TetraLogic Pharmaceuticals Completes $32 Million Series C Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 10 Aug 2010
Gregory Miller Joins Concert Pharmaceuticals as Head of Business and Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Aug 2010
Phase 3 ILLUMINATE Study Supports 24-Week Telaprevir-Based Therapy Within a Response-Guided Regimen for People with Hepatitis C Who Had Not Received Prior Treatment
Biopharmaceuticals
 HSMN NewsFeed - 10 Aug 2010
Teva Completes Acquisition of ratiopharm
Biopharmaceuticals Mergers & Acquisitions Generics
 HSMN NewsFeed - 9 Aug 2010
Pfizer Receives FDA Approval for Prefilled Dual-Chamber Syringe for Use in the Treatment of Hemophilia A
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 9 Aug 2010
Talecris Biotherapeutics and Grifols Receive FTC Request for Additional Information Regarding Proposed Merger
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Aug 2010
David T. Howard Appointed Director of biOasis Technologies Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Aug 2010
AstraZeneca Announces Agreements in Principle in SEROQUEL Product Liability Litigation
Biopharmaceuticals Litigation
 HSMN NewsFeed - 5 Aug 2010
Cornerstone Therapeutics Announces Development of Generic for Tussionex(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 5 Aug 2010
Jeffrey Wasserstein Joins Nycomed US Inc.
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 5 Aug 2010
Signum Biosciences Names Braham Shroot as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Aug 2010
Axxess Pharma, Inc. Signs Exclusive License Agreement to Globally Market and Distribute High Potency Vitamin D-3 to Help Reduce Bone Loss and Joint Pain
Biopharmaceuticals Licensing
 HSMN NewsFeed - 5 Aug 2010
Data from First Phase 3 Trial (EDEMA3(R)) for KALBITOR(R) (ecallantide) Published in The New England Journal of Medicine
Biopharmaceuticals
 HSMN NewsFeed - 4 Aug 2010
Gemin X Closes $8 Million Series E Financing
Biopharmaceuticals Venture Capital Oncology
 HSMN NewsFeed - 4 Aug 2010
Watson Names Sigurdur Oli Olafsson Executive Vice President, Global Generics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Aug 2010
FDA Approves Merz Pharmaceuticals' Xeomin(R) (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 2 Aug 2010
Aragon Pharmaceuticals Appoints Richard A. Heyman CEO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Aug 2010
Sagent Pharmaceuticals Announces Two New FDA Approvals: Sumatriptan Succinate Injection and Rocuronium Bromide Injection
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Jul 2010
Conatus Pharmaceuticals Acquires Pfizer's Idun Subsidiary
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Jul 2010
Stellar Pharmaceuticals Inc. Signs Agreement for Distribution and Sale of Uracyst(R) in Spain
Biopharmaceuticals Distribution
 HSMN NewsFeed - 29 Jul 2010
Actient Pharmaceuticals, LLC Closes Transaction to License and Acquire Specialty Pharmaceutical Products from UCB
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 29 Jul 2010
Shionogi Inc. Announces FDA Approval of CUVPOSA for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Jul 2010
Calistoga Pharmaceuticals Appoints Langdon L. Miller, M.D., Executive Vice President, Research & Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jul 2010
Abraxis BioScience and Specialised Therapeutics Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in New Zealand
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 29 Jul 2010
CMP Therapeutics Appoints Dr Neill Moray Mackenzie as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jul 2010
US Appeals Court Rules Gemzar(R) Patent Invalid
Biopharmaceuticals Generics Oncology Litigation
 HSMN NewsFeed - 29 Jul 2010
FDA Advisory Committee Recommends US FDA Approval of Brilinta (Ticagrelor) for Acute Coronary Syndromes
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 29 Jul 2010
Abbott's SIMCOR(R) (niacin extended-release / simvastatin) Receives FDA Approval for New Dosage Strengths
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 28 Jul 2010
Study Showed the Clinically Significant Therapeutic Benefit of Neupro(R) (rotigotine transdermal system) in the Treatment of Restless Legs Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 28 Jul 2010
EpiCept Amends Employment Agreement and Completes Severance Agreements with Executive Officers
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jul 2010
Caraco Pharmaceutical Laboratories, Ltd. Announces G.P. Singh Sachdeva Is Appointed as Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jul 2010
Adeona Appoints Julie A. Caudill, B.B.A., Vice President of Finance and Corporate Controller
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jul 2010
Ampio Pharmaceuticals, Inc. Announces Acquisition of DMI BioSciences, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Jul 2010
Karen Lackey Named Vice President and Head of Medicinal Chemistry at Roche
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jul 2010
FDA Approves Tribenzor, A New Three-In-One Combination Product for the Treatment of High Blood Pressure
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Jul 2010
Immune Design Corp. Raises $32 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Jul 2010
Cerenis Therapeutics and Novasep Awarded 10.7 Million Funding from The French Government For the Development CER-001, An HDL Mimetic
Biopharmaceuticals
 HSMN NewsFeed - 26 Jul 2010
Cerenis Therapeutics raises 40 million in series C financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Jul 2010
Eisai Inc. and Pfizer Inc Announce U.S. FDA Approval for New Higher-Dose Aricept(R) (donepezil HCl) 23 mg Tablet for the Treatment of Moderate-to-Severe Alzheimer's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 23 Jul 2010
Horizon Pharma, Inc. Announces Results of Phase 3 Study of LODOTRA(R) Demonstrate 12-Month Sustained Efficacy and Safety in Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 23 Jul 2010
ABRAXANE(R) Approved for Marketing in Japan for Breast Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 23 Jul 2010
Emisphere Provides an Update on Osteoarthritis Phase III Study With Oral Calcitonin
Biopharmaceuticals
 HSMN NewsFeed - 22 Jul 2010
Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jul 2010
EKR Therapeutics Names New Executive Team to Lead Company Growth in Critical Care Products Sector of Hospital Marketplace
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jul 2010
Richard B. Brewer Joins Nile Therapeutics as Executive Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jul 2010
Mylan Announces Settlement Agreement for Namenda(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 22 Jul 2010
Tarsa Therapeutics Advances Phase III ORACAL Trial of its Oral Calcitonin for the Treatment of Postmenopausal Osteoporosis
Biopharmaceuticals
 HSMN NewsFeed - 22 Jul 2010
Euthymics Bioscience, Inc. Closes $24 Million Series A Financing and Completes Acquisition of DOV Pharmaceutical
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Jul 2010
FDA provides Complete Response Letter to NicOx's New Drug Application for naproxcinod
Biopharmaceuticals
 HSMN NewsFeed - 21 Jul 2010
Radient Pharmaceuticals Announces Exclusive Distribution Agreement With AMDL Australia Pty Ltd.
Biopharmaceuticals Diagnostics Distribution
 HSMN NewsFeed - 21 Jul 2010
Keryx Biopharmaceuticals, Inc. Announces Appointment of Joseph Feczko, M.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jul 2010
Chimerix Appoints Two New Vice Presidents to Clinical Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jul 2010
Cara Therapeutics Secures $15 Million Series D Financing to Continue Clinical Development of CR845
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Jul 2010
Radient Pharmaceuticals Appoints Dr. Robert Beart Jr. MD to RPC's Board of Directors
Biopharmaceuticals Diagnostics Personnel
 HSMN NewsFeed - 20 Jul 2010
Seaside Therapeutics Appoints Leading Industry Executives to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jul 2010
Phage Pharmaceuticals Appoints David Jackson as Vice President, Operations Planning
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jul 2010
Steve Andrzejewski Joins Nycomed US Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jul 2010
TARIS Appoints Sarma Duddu as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jul 2010
Spectrum Pharmaceuticals Appoints George Tidmarsh, M.D., Ph.D, as Senior Vice President, Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jul 2010
Abbott's PROGRESS Study of Kaletra and Isentress Compared with a Standard HIV Regimen Meets the Pre-Specified Primary Efficacy Endpoint
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 17 Jul 2010
Teva Provides Update on Generic Protonix(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 16 Jul 2010
GTC Biotherapeutics Regains US Rights to ATryn(R) ; the First Recombinant Antithrombin Product Approved in the World
Biopharmaceuticals
 HSMN NewsFeed - 16 Jul 2010
Sun Pharma Announces USFDA Approval for Generic Flomax(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 15 Jul 2010
Elan Corporation, plc Reaches Agreement in Principle for Settlement of Investigation of Past Zonegran Sales and Marketing Activities
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jul 2010
Adolor Corporation Announces Restructuring
Biopharmaceuticals
 HSMN NewsFeed - 15 Jul 2010
Wound Management Technologies, Inc. Expands Distribution Channel into Five Central American Countries
Biopharmaceuticals Wound Care Distribution
 HSMN NewsFeed - 15 Jul 2010
Provectus Pharmaceuticals Reports Achieved Milestones for First Half of 2010, Recent Developments and Plans for the Remainder of the Year to Shareholders
Biopharmaceuticals Dermatology Oncology
 HSMN NewsFeed - 15 Jul 2010
Amgen Appoints Jonathan M. Peacock Executive Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jul 2010
Endo Pharmaceuticals Completes Acquisition of HealthTronics, Inc.
Biopharmaceuticals Devices Mergers & Acquisitions
 HSMN NewsFeed - 15 Jul 2010
Ikaria(R) Names Chief Science Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jul 2010
Sepracor Inc. to Become Sunovion Pharmaceuticals Inc.
Biopharmaceuticals
 HSMN NewsFeed - 14 Jul 2010
Somaxon Pharmaceuticals Establishes Silenor Commercial Team
Biopharmaceuticals
 HSMN NewsFeed - 14 Jul 2010
Mylan Receives Approval for Nabumetone Tablets
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Jul 2010
Aeterna Zentaris Announces Perifosine Has Received Orphan-Drug Designation for the Treatment of Neuroblastoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Jul 2010
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jul 2010
Trevena Secures $35 Million in Series B Funding to Progress Portfolio of GPCR Biased Ligands and to Complete Phase 2 Study of TRV120027 for Acute Heart Failure
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Jul 2010
Former Pfizer Senior Vice President Named CEO of Berlin Pharmaceutical Industry in a Partnership to Diversify and Expand Company Business in Asia
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jul 2010
Zogenix Secures $35 Million Debt Facility and Raises $15 Million Investment Capital
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 9 Jul 2010
BOTOX(R) Receives First Authorisation in UK as Preventative Treatment in Chronic Migraine
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 8 Jul 2010
iPierian Closes $22 Million Series B Financing Led By Google Ventures
Biopharmaceuticals Regenerative Medicine Venture Capital
 HSMN NewsFeed - 8 Jul 2010
Calithera Biosciences Closes $40 Million in Series A Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 8 Jul 2010
Lialda(R) - Shire Files Suit Against Cadila Healthcare Limited, Doing Business as Zydus Cadila and Zydus Pharmaceuticals (USA), Inc.
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 7 Jul 2010
MonoSol Rx Announces FDA Approval of Zuplenz(R) Oral Soluble Film for Treatment of Nausea and Vomiting
Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 7 Jul 2010
K-V Pharmaceutical Company Announces the Election of New Independent Member to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jul 2010
Acorda Therapeutics Announces Douglas Kargman Joins as Vice President of Drug Safety
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jul 2010
European Commission Approves ORENCIA in Combination with Methotrexate for Earlier Use as First-Line Biologic after DMARD Inadequate Response for the Treatment of Rheumatoid Arthritis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 7 Jul 2010
Genentech Submits Application to FDA for Trastuzumab-DM1 in Previously Treated Advanced HER2-Positive Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 Jul 2010
EpiCept Corporation Names Rita Kelley Senior Director of Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jul 2010
Novavax Announces Appointment of Dr. Gregory Glenn as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jul 2010
Three Rivers Pharmaceuticals Announces FDA Approval Of Expanded Labeling of INFERGEN
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Jul 2010
Olivier Bohuon Joins Pierre Fabre
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jul 2010
Lilly to Acquire Alnara Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 Jul 2010
BioVex Appoints Steven Kelly as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jul 2010
Lux Biosciences Names Dean Mitchell President and CEO
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 1 Jul 2010
FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Jul 2010
Shionogi Announces Reorganization of US Operations, New Leadership
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jul 2010
Cyclacel Pharmaceuticals Announces FDA Orphan Drug Designation for Sapacitabine in Both AML and MDS
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jul 2010
Eisai to Market Arena Pharmaceuticals' Lorcaserin for Obesity and Weight Management in U.S. Following FDA Approval
Biopharmaceuticals
 HSMN NewsFeed - 1 Jul 2010
Eisai Inc. Enters Marketing and Supply Agreement with Arena Pharmaceuticals for Lorcaserin
Biopharmaceuticals
 HSMN NewsFeed - 1 Jul 2010
Phase III Study Shows Novartis Drug Afinitor(R) More Than Doubles Time Without Tumor Growth in Advanced Pancreatic NET Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Jun 2010
Calistoga Pharmaceuticals Raises $40 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Jun 2010
Cornerstone Therapeutics Announces Management Change
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jun 2010
Eisai Announces Results of Phase III Study of Dacogen(R) (Decitabine) for Injection in Acute Myeloid Leukemia (AML)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Jun 2010
Raptor Pharmaceutical Announces License Agreement for Convivia(TM)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 30 Jun 2010
Celgene to Acquire Abraxis BioScience Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Jun 2010
Zymeworks Closes $3.2 Million Round of Financing and Announces the Addition of Dr. Donald Drakeman to Its Board of Directors
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 29 Jun 2010
Mylan Receives Approval for Generic Version of Arimidex(R) Tablets
Biopharmaceuticals Oncology Generics FDA
 HSMN NewsFeed - 29 Jun 2010
BIND Biosciences Secures $12.4 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Jun 2010
BIND Biosciences Appoints Ed Schnipper, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jun 2010
King Pharmaceuticals Amends Strategic Alliance for REMOXY(R) in Europe
Biopharmaceuticals
 HSMN NewsFeed - 29 Jun 2010
Teva Announces Approval of Generic Effexor XR(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 29 Jun 2010
APP Pharmaceuticals to Market Anastrozole Tablets in the U.S.
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Jun 2010
Bayer HealthCare Introduces First Mobile Application to Assist Hemophilia A Patients in Managing Their Treatment
Biopharmaceuticals
 HSMN NewsFeed - 28 Jun 2010
New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes
Biopharmaceuticals
 HSMN NewsFeed - 28 Jun 2010
New High-Resolution Computer Tomography Data Demonstrates EVISTA(R)'s Effect on Bone Quality in Osteoporotic Patients
Biopharmaceuticals
 HSMN NewsFeed - 25 Jun 2010
Gilead Sciences to Acquire CGI Pharmaceuticals for up to $120 Million
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Jun 2010
Investigational BRINAVESS (vernakalant) for Infusion Recommended for Approval by the CHMP in the European Union (EU) for the Rapid Conversion of Recent Onset Atrial Fibrillation
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 24 Jun 2010
FDA Approves Merck's DULERA(R) (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol for the Treatment of Asthma in Patients 12 Years of Age and Older
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Jun 2010
t2cure's Cellular Therapeutic Receives Orphan Drug Designation from FDA, EMA Recommendation for Buerger's Disease
Biopharmaceuticals Regenerative Medicine FDA Regulatory
 HSMN NewsFeed - 23 Jun 2010
Valeant Pharmaceuticals Resumes Shipment of Oxsoralen-Ultra(R)
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 23 Jun 2010
ARIAD Names Timothy P. Clackson to New Position of President of Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jun 2010
Spectrum Pharmaceuticals Appoints James E. Shields as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jun 2010
Hospira Receives FDA Approval for Meropenem for Injection, USP (I.V.)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 22 Jun 2010
Spencer Pharmaceutical Inc. Announces New President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jun 2010
QLT Announces Final Results From Its RADICAL Study Evaluating Verteporfin PDT (Visudyne(R)) Combination Therapy in Exudative AMD
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 22 Jun 2010
Ipsen: Encouraging results of GuidAge(R), large scale European trial conducted in the prevention of Alzheimer's Dementia
Biopharmaceuticals Neurology
 HSMN NewsFeed - 21 Jun 2010
Pfizer Prepares for Voluntary Withdrawal of U.S. New Drug Application and for Discontinuation of Commercial Availability of Mylotarg(R)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Jun 2010
New Head-to-Head Phase 3 Study Evaluated Systolic Blood Pressure Reduction of Investigational Compound Azilsartan Medoxomil Compared to Valsartan
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 21 Jun 2010
NormOxys Appoints Dr. John A. Hey Senior Vice President of Preclinical and Early Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jun 2010
Sosei to Acquire Activus Pharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Jun 2010
Valeant and Biovail Agree to Merge
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Jun 2010
Exelixis Regains Full Rights to Develop and Commercialize XL184
Biopharmaceuticals
 HSMN NewsFeed - 21 Jun 2010
APP Pharmaceuticals Announces Approval and Launch of First Generic Aztreonam for Injection, USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 18 Jun 2010
Medicis Announces Organizational Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jun 2010
Neupro(R) (rotigotine) significantly improved wellbeing and daily activities impaired due to limb pain associated with Restless Legs Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 18 Jun 2010
Lonnel Coats Appointed President & Chief Executive Officer of Eisai Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jun 2010
Aquinox Pharmaceuticals Completes US $25 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Jun 2010
Marshall Edwards Announces Additional Management Changes With Appointment of New Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 Jun 2010
Neupro(R) (rotigotine transdermal system) Showed Significant Benefit on Early Morning Motor Control, Sleep and Nocturnal Symptoms in Patients With Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 17 Jun 2010
MonoSol Rx Appoints Dr. Mary Ellen Norvitch Vice President of Regulatory Affairs, Clinical Affairs and Quality Assurance
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 17 Jun 2010
Bayer and OncoMed Pharmaceuticals Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
Biopharmaceuticals Regenerative Medicine Oncology
 HSMN NewsFeed - 17 Jun 2010
OncoMed Pharmaceuticals and Bayer Schering Pharma Announce Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
Biopharmaceuticals Regenerative Medicine Oncology
Older Biopharmaceutical stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!